As GSK, Merck Slash Rotavirus Vaccine Prices, Bharat Biotech Eyes Supplies At $1 Per Shot
This article was originally published in The Pink Sheet Daily
Executive Summary
Bharat Biotech's rotavirus development is a public-private initiative with partners including the Indian government, CDC and NIH.